BREAKING: Pfizer Coronavirus VACCINE Looks POSITIVE In Early Tests

By John Paluska, Founder of The Daily Fodder

News just dropped of Pfizer's Coronavirus vaccine looking successful in early testing. This positive report is likely coming out because Gilead's Remdesivir is expected to cost up to $3,120 a treatment, signaling a much more affordable solution is needed.

News Center Maine reports:

The first of four experimental COVID-19 vaccines being tested by Pfizer and its German partner BioNTech showed encouraging results in very early testing of 45 people, the companies said Wednesday.

Study volunteers given either a low or medium dose, in two shots about a month apart, had immune responses in the range expected to be protective, when compared to some COVID-19 survivors, according to the preliminary results.

Side effects were typical for vaccines, mostly pain at the injection site and fever.

The report has been submitted for publication in a scientific journal but not yet reviewed. With its other potential candidates still in the earliest stage of testing, Pfizer aims to open a large-scale study this summer but can't yet say which shot is best to include.

But researchers didn’t administer a second shot of the highest dose initially tested, sticking with the low and medium doses. The higher-dose shot caused more injection reactions without apparent added benefit.

Granted, this is information from Pfizer itself, so there hasn't been any third-party verification or independent studies on either effectiveness or safety. Companies are known for faking their safety and efficacy, especially in vaccines. So before you go out and get this vaccine, wait for independent proof. Or maybe take some Zinc Acetate instead.

HELP STOP THE SPREAD OF FAKE NEWS!

SHARE our articles and like our Facebook page and follow us on Twitter!